Related Experiment Videos
Induction of apoptosis by the tumor suppressor protein BRCA1
1Department of Microbiology and Immunology, Jefferson Medical College, Kimmel Cancer Institute, Pennsylvania 19107-5541, USA.
Abstract:
The breast and ovarian cancer susceptibility gene BRCA1, is a nuclear phosphoprotein which functions as a tumor suppressor. To investigate the role of BRCA1 in apoptosis, we have developed mouse fibroblast cell lines and human breast cancer cell lines expressing BRCA1. The expression of BRCA1 protein in the BRCA1 transfectants were analysed by immunofluorescence and immunohistochemistry. The BRCA1 transfectants showed a flattened morphology compared to the parental cells. We show that serum deprivation or calcium ionophore treatment of BRCA1 transfectants resulted in programmed cell death. These results indicate that BRCA1 genes may play a critical role in the regulation of apoptosis. Thus, since a wide variety of human malignancies like breast and ovarian cancers have a decreased ability to undergo apoptosis, this could be due to lack/decreased levels of functional BRCA1 proteins. Treatments that are aimed at increasing the apoptotic threshold by BRCA1 gene therapy may have the potential to prevent the progression of these malignancies.
Insights
The BRCA1 gene, a tumor suppressor, plays a critical role in programmed cell death (apoptosis). Introducing BRCA1 into cells enhanced their susceptibility to apoptosis, suggesting a link between BRCA1 deficiency and cancer progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- BRCA1 is a tumor suppressor gene linked to breast and ovarian cancers.
- Its precise role in regulating apoptosis, or programmed cell death, requires further investigation.
Purpose of the Study:
- To investigate the function of BRCA1 in regulating apoptosis.
- To develop and utilize cell models for studying BRCA1's impact on cell death.
Main Methods:
- Developed mouse fibroblast and human breast cancer cell lines engineered to express BRCA1.
- Analyzed BRCA1 protein expression using immunofluorescence and immunohistochemistry.
- Assessed programmed cell death induction via serum deprivation and calcium ionophore treatment.
Main Results:
- BRCA1-expressing cells exhibited a flattened morphology compared to control cells.
- BRCA1 transfectants showed increased susceptibility to programmed cell death under specific stress conditions.
- These findings implicate BRCA1 in the regulation of apoptosis.
Conclusions:
- BRCA1 plays a significant role in controlling programmed cell death.
- Deficiency in functional BRCA1 may contribute to the reduced apoptosis observed in malignancies like breast and ovarian cancers.
- BRCA1 gene therapy could be a potential strategy to enhance apoptosis and prevent cancer progression.